Lifevantage Shares Are Trading Higher After the Company Announced the Completion of a Successful 12-week Clinical Trial on Its New GLP-1 System for Weight Loss.
Lifevantage Shares Are Trading Higher After the Company Announced the Completion of a Successful 12-week Clinical Trial on Its New GLP-1 System for Weight Loss.
lifevantage股價上漲，公司宣佈其新GLP-1減肥系統成功完成12周臨床試驗。
Lifevantage Shares Are Trading Higher After the Company Announced the Completion of a Successful 12-week Clinical Trial on Its New GLP-1 System for Weight Loss.
Lifevantage宣佈成功完成其新型 GLP-1 減肥系統的爲期12周的臨床試驗，此後，該公司股價走高。